NCT06562673 2025-12-29
IACE-OS
Shanghai 6th People's Hospital
Phase 1/2 Completed
Clinical Trials
12 trialsNCT03086681 2025-07-29
ECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT03797625 2025-07-23
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Phase 2 Completed
NCT02350517 2023-02-16
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT02237924 2022-02-14
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
NCT02444949 2020-06-24
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Completed
NCT03121833 2019-12-26
Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT00849264 2016-04-01
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT01687439 2012-09-19
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
Fudan University
Phase 2 Completed
NCT01124253 2010-05-17
Dengshan
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed